The common shares of Spackman Equities Group trades on the TSX Venture Exchange under the symbol SQG. Visit www.spackmanequities.com for further information.

The only daughter of the late Queen Elizabeth II, Princess Anne has played an active role in the British royal family for decades. Even as she gets older, the Princess Royal says she has no ...

Enhertu is approved for HR-positive, HER2-low or -ultralow metastatic breast cancer, expanding treatment options for these patients. DESTINY-Breast06 trial showed Enhertu reduced disease progression ...

Adding nivolumab to neoadjuvant chemotherapy significantly increases pathological complete response rates. (HealthDay News) — For patients with high-risk, early-stage estrogen receptor (ER ...

Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer. All patients with breast cancer who may be candidates for antibody-drug ...

Test The FDA has expanded the approval for the PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody to include patients with HR+, HER2-ultralow metastatic breast cancer who may benefit from ...

In the HER2-low population, treatment with trastuzumab deruxtecan reduced the risk of disease progression or death by 38% compared with chemotherapy. The Food and Drug Administration (FDA ...

of German Breast Group in Neu-Isenburg, the Centre for Haematology and Oncology Bethanien in Frankfurt, and Goethe University of Frankfurt, all in Germany, said in a presentation of the findings. The ...